Loading…

WBC subset analysis of WBC-reduced platelet components

BACKGROUND: WBC‐reduced platelet components may be prepared by filtration or apheresis processing. Both methods have previously been shown to result in a residual total WBC content

Saved in:
Bibliographic Details
Published in:Transfusion (Philadelphia, Pa.) Pa.), 2000-07, Vol.40 (7), p.771-780
Main Authors: Triulzi, D.J., Meyer, E.M., Donnenberg, A.D.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4981-972f1176a665d1a60c00f89980d7b50da352eb5b92d4331999432176c4845e703
cites cdi_FETCH-LOGICAL-c4981-972f1176a665d1a60c00f89980d7b50da352eb5b92d4331999432176c4845e703
container_end_page 780
container_issue 7
container_start_page 771
container_title Transfusion (Philadelphia, Pa.)
container_volume 40
creator Triulzi, D.J.
Meyer, E.M.
Donnenberg, A.D.
description BACKGROUND: WBC‐reduced platelet components may be prepared by filtration or apheresis processing. Both methods have previously been shown to result in a residual total WBC content
doi_str_mv 10.1046/j.1537-2995.2000.40070771.x
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71747605</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71747605</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4981-972f1176a665d1a60c00f89980d7b50da352eb5b92d4331999432176c4845e703</originalsourceid><addsrcrecordid>eNqVkE1r20AQhpfS0DhO_kIRtOQmZfZbS0-tW7sJxgnBIcdltVqBXFlytRKx_31WyHF7zWmZnWfeGR6EvmBIMDBxs0kwpzImSvGEAEDCACRIiZP9BzQ59T6iCQDDMcaUnKML7zeBJQrwJ3SOQREmgE6QeP4xi3yfeddFpjbVwZc-aooofMety3vr8mhXmc5VAbDNdtfUru78JTorTOXd1fGdoqf5r_Xsd7y8X9zOvi9jy1SKYyVJgbEURgieYyPAAhSpUinkMuOQG8qJy3imSM4oxUopRkngLUsZdxLoFF2Pubu2-ds73-lt6a2rKlO7pvdaYsmkAB7AbyNo28b71hV615Zb0x40Bj1o0xs9qNGDGj1o02_a9D5Mfz6u6bOty_-bHT0F4OsRMN6aqmhNbUv_j2MsxA7n_hyxl7Jyh_ecoNeP87cqxMRjTOk7tz_FmPaPFpJKrp9XC71cPzyo9G6lV_QVa86WEA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71747605</pqid></control><display><type>article</type><title>WBC subset analysis of WBC-reduced platelet components</title><source>Wiley</source><creator>Triulzi, D.J. ; Meyer, E.M. ; Donnenberg, A.D.</creator><creatorcontrib>Triulzi, D.J. ; Meyer, E.M. ; Donnenberg, A.D.</creatorcontrib><description>BACKGROUND: WBC‐reduced platelet components may be prepared by filtration or apheresis processing. Both methods have previously been shown to result in a residual total WBC content &lt;5 × 106 per component. However, there may be differences in the efficacy of these techniques for removing certain WBC subsets. STUDY DESIGN AND METHODS: Two multiparameter flow cytometric assays were developed and validated to perform WBC analysis on WBC‐reduced platelets collected with two apheresis instruments (Amicus and COBE Spectra) and on 6 units of filtered pooled random‐donor platelet concentrates. RESULTS: All components contained &lt;1 × 105 WBCs. The COBE Spectra and Amicus apheresis platelet components contained more WBCs than did filtered pooled platelets (p&lt;0.05). Lymphocytes (T and B), monocytes, and granulocytes were identified in all components. Granulocyte content was lowest in the Amicus components and filtered pools. Monocytes were lowest in filtered pools. Amicus platelet components had fewer granulocytes and monocytes than the COBE Spectra platelets. Amicus and COBE Spectra components contained more lymphocytes than the filtered pools. CONCLUSION: Multiparameter flow cytometry can be used to quantify and characterize WBCs in WBC‐reduced platelet components. WBC reduction by filtration or apheresis was highly effective. WBCs from each subset were identified in all components. Although filtered pools had the lowest numbers of WBCs, the very low numbers observed in all components suggests that the absolute quantitative differences in WBC subset content are of questionable clinical significance.</description><identifier>ISSN: 0041-1132</identifier><identifier>EISSN: 1537-2995</identifier><identifier>DOI: 10.1046/j.1537-2995.2000.40070771.x</identifier><identifier>PMID: 10924603</identifier><identifier>CODEN: TRANAT</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Science Inc</publisher><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Biological and medical sciences ; Blood Cell Count ; Blood Platelets - cytology ; Blood. Blood and plasma substitutes. Blood products. Blood cells. Blood typing. Plasmapheresis. Apheresis ; BSG-C = buffered saline glucose-citrate ; cRBC(s) = chicken RBC(s) ; Flow Cytometry - methods ; Humans ; Medical sciences ; PI = propidium iodide ; Plateletpheresis - methods ; RDP(s) = random-donor platelet concentrate(s) ; SDP(s) = single-donor apheresis platelet(s) ; Sensitivity and Specificity ; Transfusions. Complications. Transfusion reactions. Cell and gene therapy</subject><ispartof>Transfusion (Philadelphia, Pa.), 2000-07, Vol.40 (7), p.771-780</ispartof><rights>2000 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4981-972f1176a665d1a60c00f89980d7b50da352eb5b92d4331999432176c4845e703</citedby><cites>FETCH-LOGICAL-c4981-972f1176a665d1a60c00f89980d7b50da352eb5b92d4331999432176c4845e703</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1449950$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10924603$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Triulzi, D.J.</creatorcontrib><creatorcontrib>Meyer, E.M.</creatorcontrib><creatorcontrib>Donnenberg, A.D.</creatorcontrib><title>WBC subset analysis of WBC-reduced platelet components</title><title>Transfusion (Philadelphia, Pa.)</title><addtitle>Transfusion</addtitle><description>BACKGROUND: WBC‐reduced platelet components may be prepared by filtration or apheresis processing. Both methods have previously been shown to result in a residual total WBC content &lt;5 × 106 per component. However, there may be differences in the efficacy of these techniques for removing certain WBC subsets. STUDY DESIGN AND METHODS: Two multiparameter flow cytometric assays were developed and validated to perform WBC analysis on WBC‐reduced platelets collected with two apheresis instruments (Amicus and COBE Spectra) and on 6 units of filtered pooled random‐donor platelet concentrates. RESULTS: All components contained &lt;1 × 105 WBCs. The COBE Spectra and Amicus apheresis platelet components contained more WBCs than did filtered pooled platelets (p&lt;0.05). Lymphocytes (T and B), monocytes, and granulocytes were identified in all components. Granulocyte content was lowest in the Amicus components and filtered pools. Monocytes were lowest in filtered pools. Amicus platelet components had fewer granulocytes and monocytes than the COBE Spectra platelets. Amicus and COBE Spectra components contained more lymphocytes than the filtered pools. CONCLUSION: Multiparameter flow cytometry can be used to quantify and characterize WBCs in WBC‐reduced platelet components. WBC reduction by filtration or apheresis was highly effective. WBCs from each subset were identified in all components. Although filtered pools had the lowest numbers of WBCs, the very low numbers observed in all components suggests that the absolute quantitative differences in WBC subset content are of questionable clinical significance.</description><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Biological and medical sciences</subject><subject>Blood Cell Count</subject><subject>Blood Platelets - cytology</subject><subject>Blood. Blood and plasma substitutes. Blood products. Blood cells. Blood typing. Plasmapheresis. Apheresis</subject><subject>BSG-C = buffered saline glucose-citrate</subject><subject>cRBC(s) = chicken RBC(s)</subject><subject>Flow Cytometry - methods</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>PI = propidium iodide</subject><subject>Plateletpheresis - methods</subject><subject>RDP(s) = random-donor platelet concentrate(s)</subject><subject>SDP(s) = single-donor apheresis platelet(s)</subject><subject>Sensitivity and Specificity</subject><subject>Transfusions. Complications. Transfusion reactions. Cell and gene therapy</subject><issn>0041-1132</issn><issn>1537-2995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><recordid>eNqVkE1r20AQhpfS0DhO_kIRtOQmZfZbS0-tW7sJxgnBIcdltVqBXFlytRKx_31WyHF7zWmZnWfeGR6EvmBIMDBxs0kwpzImSvGEAEDCACRIiZP9BzQ59T6iCQDDMcaUnKML7zeBJQrwJ3SOQREmgE6QeP4xi3yfeddFpjbVwZc-aooofMety3vr8mhXmc5VAbDNdtfUru78JTorTOXd1fGdoqf5r_Xsd7y8X9zOvi9jy1SKYyVJgbEURgieYyPAAhSpUinkMuOQG8qJy3imSM4oxUopRkngLUsZdxLoFF2Pubu2-ds73-lt6a2rKlO7pvdaYsmkAB7AbyNo28b71hV615Zb0x40Bj1o0xs9qNGDGj1o02_a9D5Mfz6u6bOty_-bHT0F4OsRMN6aqmhNbUv_j2MsxA7n_hyxl7Jyh_ecoNeP87cqxMRjTOk7tz_FmPaPFpJKrp9XC71cPzyo9G6lV_QVa86WEA</recordid><startdate>200007</startdate><enddate>200007</enddate><creator>Triulzi, D.J.</creator><creator>Meyer, E.M.</creator><creator>Donnenberg, A.D.</creator><general>Blackwell Science Inc</general><general>Blackwell Publishing</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200007</creationdate><title>WBC subset analysis of WBC-reduced platelet components</title><author>Triulzi, D.J. ; Meyer, E.M. ; Donnenberg, A.D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4981-972f1176a665d1a60c00f89980d7b50da352eb5b92d4331999432176c4845e703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Biological and medical sciences</topic><topic>Blood Cell Count</topic><topic>Blood Platelets - cytology</topic><topic>Blood. Blood and plasma substitutes. Blood products. Blood cells. Blood typing. Plasmapheresis. Apheresis</topic><topic>BSG-C = buffered saline glucose-citrate</topic><topic>cRBC(s) = chicken RBC(s)</topic><topic>Flow Cytometry - methods</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>PI = propidium iodide</topic><topic>Plateletpheresis - methods</topic><topic>RDP(s) = random-donor platelet concentrate(s)</topic><topic>SDP(s) = single-donor apheresis platelet(s)</topic><topic>Sensitivity and Specificity</topic><topic>Transfusions. Complications. Transfusion reactions. Cell and gene therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Triulzi, D.J.</creatorcontrib><creatorcontrib>Meyer, E.M.</creatorcontrib><creatorcontrib>Donnenberg, A.D.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Transfusion (Philadelphia, Pa.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Triulzi, D.J.</au><au>Meyer, E.M.</au><au>Donnenberg, A.D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>WBC subset analysis of WBC-reduced platelet components</atitle><jtitle>Transfusion (Philadelphia, Pa.)</jtitle><addtitle>Transfusion</addtitle><date>2000-07</date><risdate>2000</risdate><volume>40</volume><issue>7</issue><spage>771</spage><epage>780</epage><pages>771-780</pages><issn>0041-1132</issn><eissn>1537-2995</eissn><coden>TRANAT</coden><abstract>BACKGROUND: WBC‐reduced platelet components may be prepared by filtration or apheresis processing. Both methods have previously been shown to result in a residual total WBC content &lt;5 × 106 per component. However, there may be differences in the efficacy of these techniques for removing certain WBC subsets. STUDY DESIGN AND METHODS: Two multiparameter flow cytometric assays were developed and validated to perform WBC analysis on WBC‐reduced platelets collected with two apheresis instruments (Amicus and COBE Spectra) and on 6 units of filtered pooled random‐donor platelet concentrates. RESULTS: All components contained &lt;1 × 105 WBCs. The COBE Spectra and Amicus apheresis platelet components contained more WBCs than did filtered pooled platelets (p&lt;0.05). Lymphocytes (T and B), monocytes, and granulocytes were identified in all components. Granulocyte content was lowest in the Amicus components and filtered pools. Monocytes were lowest in filtered pools. Amicus platelet components had fewer granulocytes and monocytes than the COBE Spectra platelets. Amicus and COBE Spectra components contained more lymphocytes than the filtered pools. CONCLUSION: Multiparameter flow cytometry can be used to quantify and characterize WBCs in WBC‐reduced platelet components. WBC reduction by filtration or apheresis was highly effective. WBCs from each subset were identified in all components. Although filtered pools had the lowest numbers of WBCs, the very low numbers observed in all components suggests that the absolute quantitative differences in WBC subset content are of questionable clinical significance.</abstract><cop>Oxford, UK</cop><pub>Blackwell Science Inc</pub><pmid>10924603</pmid><doi>10.1046/j.1537-2995.2000.40070771.x</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0041-1132
ispartof Transfusion (Philadelphia, Pa.), 2000-07, Vol.40 (7), p.771-780
issn 0041-1132
1537-2995
language eng
recordid cdi_proquest_miscellaneous_71747605
source Wiley
subjects Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Biological and medical sciences
Blood Cell Count
Blood Platelets - cytology
Blood. Blood and plasma substitutes. Blood products. Blood cells. Blood typing. Plasmapheresis. Apheresis
BSG-C = buffered saline glucose-citrate
cRBC(s) = chicken RBC(s)
Flow Cytometry - methods
Humans
Medical sciences
PI = propidium iodide
Plateletpheresis - methods
RDP(s) = random-donor platelet concentrate(s)
SDP(s) = single-donor apheresis platelet(s)
Sensitivity and Specificity
Transfusions. Complications. Transfusion reactions. Cell and gene therapy
title WBC subset analysis of WBC-reduced platelet components
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T00%3A01%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=WBC%20subset%20analysis%20of%20WBC-reduced%20platelet%20components&rft.jtitle=Transfusion%20(Philadelphia,%20Pa.)&rft.au=Triulzi,%20D.J.&rft.date=2000-07&rft.volume=40&rft.issue=7&rft.spage=771&rft.epage=780&rft.pages=771-780&rft.issn=0041-1132&rft.eissn=1537-2995&rft.coden=TRANAT&rft_id=info:doi/10.1046/j.1537-2995.2000.40070771.x&rft_dat=%3Cproquest_cross%3E71747605%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4981-972f1176a665d1a60c00f89980d7b50da352eb5b92d4331999432176c4845e703%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=71747605&rft_id=info:pmid/10924603&rfr_iscdi=true